Synapse Open Synapse
Biology

FDA approves pioneering breast cancer drug that nips resistance in the bud

Nature Biotechnology · · 8 min read

A breast cancer drug linked with a test to detect ESR1 mutations in circulating tumor DNA is one of a wave of new drugs developed to tackle resistance to estrogen-receptor-targeted therapies.

Latest from Nature Biotechnology